Cracking the code for H5N1-bird flu and beyond

Current Drug Delivery

Volumn 6, Issue 4, 2009, Pages 343-346

  Thomson, Robin J ^a   Haselhorst, Thomas ^a   Dyason, Jeffrey C ^a   Von Itzstein, Mark ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Anti virals; Carbohydrates; Influenza virus; Nuclear magnetic resonance spectroscopy; Structural biology

Indexed keywords

AMANTADINE; CARBOHYDRATE; INFLUENZA VACCINE; N ACETYLNEURAMINIC ACID; OSELTAMIVIR; RIBAVIRIN; SIALIDASE INHIBITOR; VIRUS GLYCOPROTEIN; VIRUS HEMAGGLUTININ; ZANAMIVIR;

ANTIVIRAL THERAPY; AVIAN INFLUENZA; DRUG PROTEIN BINDING; DRUG RESEARCH; DRUG STRUCTURE; INFLUENZA; INFLUENZA VIRUS A H5N1; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PANDEMIC; PRIORITY JOURNAL; REVIEW; VIRUS STRAIN;

ANTIVIRAL AGENTS; CARBOHYDRATE METABOLISM; DRUG DESIGN; DRUG RESISTANCE, VIRAL; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 68949148962     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720109789000555     Document Type: Review

References (32)

1. Zambon, M. C. The pathogenesis of influenza in humans. Rev. Med. Virol., 2001, 11, 227-241.
2. World Health Organisation, Fact sheet No211: Influenza. 2003: http://www.who.int/mediacentre/factsheets/fs211/en/
3. Australian Government - Department of Health and Ageing, Australian Influenza Report: Report No. 12 (Fortnight ending 7 November 2008).
4. Murray, C. J. L.; Lopez, A. D.; Chin, B.; Feehan, D.; Hill, K. H. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-1920 pandemic: a quantitative analysis. Lancet, 2006, 368, 2211-2218.
5. Peiris, J. S. M.; de Jong, M. D.; Guan, Y. Avian influenza virus (H5N1): a threat to human health. Clin. Microbiol. Rev., 2007, 20, 243-267. (Pubitemid 46709304)
6. Abdel-Ghafar, A.-N.; Chotpitayasunondh, T.; Gao, Z.; Hayden, F. G.; Nguyen, D. H.; de Jong, M. D.; Naghdaliyev, A.; Peiris, J. S. M.; Shindo, N.; Soeroso, S.; Uyeki, T. M. Update on avian influenza A (H5N1) virus infection in humans. N. Engl. J. Med., 2008, 358, 261-273.
7. Nicholson, K. G.; Wood, J. M.; Zambon, M. Influenza. Lancet, 2003, 362, 1733-1745.
8. Skehel, J. J.; Wiley, D. C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Ann. Rev. Biochem., 2000, 69, 531-569.
9. Wagner, R.; Matrosovich, M.; Klenk, H.-D. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev. Med. Virol., 2002, 12, 159-166.
10. Stevens, J.; Blixt, O.; Paulson, J. C.; Wilson, I. A. Glycan microarray technologies: tools to survey host specificity of influenza viruses. Nat. Rev. Microbiol., 2006, 4, 857-864.
11. Matrosovich, M. N.; Matrosovich, T. Y.; Gray, T.; Roberts, N. A.; Klenk, H.-D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA, 2004, 101, 4620-4624.
12. Wan, H.; Sorrell, E. M.; Song, H.; Hossain, M. J.; Ramirez-Nieto, G.; Monne, I.; Stevens, J.; Cattoli, G.; Capua, I.; Chen, L.-M.; Donis, R. O.; Busch, J.; Paulson, J. C.; Brockwell, C.; Webby, R.; Blanco, J.; Al-Natour, M. Q.; Perez, D. R. Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS ONE, 2008, 3, e2923.
13. Glaser, L.; Stevens, J.; Zamarin, D.; Wilson, I. A.; Garcia-Sastre, A.; Tumpey, T. M.; Basler, C. F.; Taubenberger, J. K.; Palese, P. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J. Virol., 2005, 79, 11533-11536.
14. Stray, S. J.; Cummings, R. D.; Air, G. M. Influenza virus infection of desialylated cells. Glycobiology, 2000, 10, 649-658. (Pubitemid 30616200)
15. Nicholls, J. M.; Chan, M. C. W.; Chan, W. Y.; Wong, H. K.; Cheung, C. Y.; Kwong, D. L. W.; Wong, M. P.; Chui, W. H.; Poon, L. L. M.; Tsao, S. W.; Guan, Y.; Peiris, J. S. M. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat. Med., 2007, 13, 147-149. (Pubitemid 46245761)
16. Sauter, N. K.; Glick, G. D.; Crowther, R. L.; Park, S.-J.; Eisen, M. B.; Skehel, J. J.; Knowles, J. R.; Wiley, D. C. Crystallographic detection of a second ligand binding site in influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA, 1992, 89, 324-328.
17. Rapoport, E. M.; Mochalova, L. V.; Gabius, H.-J.; Romanova, J.; Bovin, N. V. Search for additional influenza virus to cell interactions. Glycoconjug. J., 2006, 23, 115-125.
18. Hausmann, J.; Kretzschmar, E.; Garten, W.; Klenk, H.-D. N1 Neuraminidase of influenza virus A/FPV/Rostock/34 has haemadsorbing activity. J. Gen. Virol., 1995, 76, 1719-1728.
19. Varghese, J. N.; Colman, P. M.; Van Donkelaar, A.; Blick, T. J.; Sahasrabudhe, A.; McKimm-Breschkin, J. L. Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases. Proc. Natl. Acad. Sci. USA, 1997, 94, 11808-11812.
20. von Itzstein, M. The war against influenza: discovery and development of sialidase inhibitors. Nat. Rev. Drug Discov., 2007, 6, 967-974. (Pubitemid 350201787)
21. von Itzstein, M.; Thomson, R. Anti-influenza drugs: the development of sialidase inhibitors. Handb. Exp. Pharmacol., 2009, 189, 111-154.
22. Reece, P. A. Neuraminidase inhibitor resistance in influenza viruses. J. Med. Virol., 2007, 79, 1577-1586.
23. Meijer, A.; Lackenby, A.; Hungnes, O.; Lina, B.; van der Werf, S.; Schweiger, B.; Opp, M.; Paget, J.; van de Kassteele, J.; Hay, A.; Zambon, M. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg. Infect. Dis., 2009, 15, 552-560.
24. Singer, A. C.; Nunn, M. A.; Gould, E. A.; Johnson, A. C. Potential risks associated with the proposed widespread use of Tamiflu. Environ. Health Persp., 2007, 115, 102-106.
25. Ilyushina, N. A.; Bovin, N. V.; Webster, R. G.; Govorkova, E. A. Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants. Antiviral Res., 2006, 70, 121-131.
26. Madren, L. K.; Shipman, C., Jr.; Hayden, F. G. In vitro inhibitory effects of combinations of anti-influenza agents. Antiviral Chem. Chemother., 1995, 6, 109-113.
27. Russell, R. J.; Haire, L. F.; Stevens, D. J.; Collins, P. J.; Lin, Y. P.; Blackburn, G. M.; Hay, A. J.; Gamblin, S. J.; Skehel, J. J. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature, 2006, 443, 45-49.
28. Mayer, M.; Meyer, B. Characterization of ligand binding by Saturation Transfer Difference NMR spectroscopy. Angew. Chem., Int. Ed., 1999, 38, 1784-1788. (Pubitemid 29290947)
29. Angulo, J.; Rademacher, C.; Biet, T.; Benie, A. J.; Blume, A.; Peters, H.; Palcic, M.; Parra, F.; Peters, T. NMR analysis of carbohydrate- protein interactions. Methods Enzymol., 2006, 416, 12-30. (Pubitemid 44750102)
30. Haselhorst, T.; Lamerz, A. C.; Itzstein, M. Saturation transfer difference NMR spectroscopy as a technique to investigate proteincarbohydrate interactions in solution. Methods Mol. Biol., 2009, 534, 375-386.
31. Haselhorst, T.; Garcia, J.-M.; Islam, T.; Lai, J. C. C.; Rose, F. J.; Nicholls, J. M.; Peiris, J. S. M.; von Itzstein, M. Avian influenza H5-containing virus-like particles (VLPs): host-cell receptor specificity by STD NMR spectroscopy. Angew. Chem., Int. Ed., 2008, 47, 1910-1912.
32. Nefkens, I.; Garcia, J.-M.; Ling, C. S.; Lagarde, N.; Nicholls, J.; Tang, D. J.; Peiris, M.; Buchy, P.; Altmeyer, R. Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis. J. Clin. Virol., 2007, 39, 27-33. (Pubitemid 46575342)